Abivax SA Statistics
NASDAQ: ABVXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
87.01-1.21 (-1.37%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Abivax SA by the numbers
Abivax SA has a market capitalization of $7.59 billion based on 87.27M shares outstanding. With trailing EPS of $-6.08, Abivax SA is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.8% below its 50-day average and 26.0% below its 200-day average.
Average daily trading volume is 1.09M shares, or about $94.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ABVX valuation vs. peer median
| Metric | ABVX | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.59B | $7.55B | +1% |
| Avg. volume | 1.09M | 1.93M | -43% |
Peer median across 8 companies: PRAX, IONS, TGTX, SYRE, ALKS, CYTK, AMRX, ARWR.
Valuation
- Market cap
- $7.59B
- EPS (TTM)
- $-6.08
- Shares outstanding
- 87.27M
Price and trading
- Previous close
- 88.22
- Open
- 86.86
- Day range
- 86.00 – 88.46
- 52-week range
- 69.81 – 148.83
- 52-week change
- 0.00%
- 50-day moving average
- 112.75
- 200-day moving average
- 117.63
- Beta
- —
- Volume
- 1.39M
- Average volume
- 1.09M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Sep 21, 2026
Additional statistics
- Market Cap
- 7.59B
- Forward Pe
- -22.42
- Eps
- -6.08
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 148.83
- Week52 Low
- 69.81
- Avg Volume
- 1.09M
- Shares Outstanding
- 87.27M
- Ma50
- 112.75
- Ma200
- 117.63
- Earnings Date
- Sep 21, 2026
- Pct From52w High
- -41.54%
- Pct From52w Low
- 24.64%